REDUCE LAP-HF II interatrial shunt trial: neutral, but necessary
Navin K Kapur1, Jenica N Upshaw1, Benjamin S Wessler1
1CardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Lancet (London, England)
|February 5, 2022
Abstract
No abstract available in PubMed .


